Certified Diabetes Educator Practice Exam 2025 - Free Practice Questions and Study Resource.

The primary action of Acarbose and Miglitol in diabetes treatment is to delay carbohydrate absorption. Both of these medications belong to a class of drugs known as alpha-glucosidase inhibitors. They work by inhibiting the enzymes in the intestines that are responsible for breaking down complex carbohydrates into simple sugars. By doing so, they slow down the digestion and absorption of carbohydrates, which helps to reduce spikes in blood glucose levels after meals. This mechanism is particularly beneficial for individuals with type 2 diabetes, as it helps to manage postprandial (after meal) blood glucose levels effectively.

Using this approach offers patients a way to control their glycemic response without requiring significant alterations to their overall diet. This delayed absorption can also lead to reduced overall caloric intake, supporting weight management, which is often an important aspect of diabetes care. While stimulation of insulin production, increasing insulin sensitivity, and reducing hepatic glucose output are vital factors in blood glucose control, they are not the primary actions of Acarbose and Miglitol.